tiprankstipranks
Trending News
More News >
Quest Diagnostics (DGX)
:DGX
US Market
Advertisement

Quest Diagnostics (DGX) Earnings Dates, Call Summary & Reports

Compare
951 Followers

Earnings Data

Report Date
Oct 28, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
2.5
Last Year’s EPS
2.3
Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 22, 2025|
% Change Since: -3.25%|
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook for Quest Diagnostics, highlighting robust revenue and EPS growth, successful acquisitions, and operational improvements. While there are concerns regarding tariffs and potential healthcare policy impacts, the overall performance and future guidance are strong.
Company Guidance -
Q3 2025
In the second quarter of 2025, Quest Diagnostics reported robust financial performance, leading to an upward revision of their full-year guidance. The company achieved a 15.2% top-line growth, driven by 5.2% organic revenue growth and significant contributions from recent acquisitions. Adjusted earnings per share (EPS) increased by 11.5%, supported by productivity gains from automation and advanced technologies. Consolidated revenues for the quarter reached $2.76 billion, with diagnostic information services revenues up by 15.7%. The reported EPS stood at $2.47, while adjusted EPS was $2.62. Quest raised its full-year revenue guidance to between $10.8 billion and $10.92 billion, with adjusted EPS expected to be in the range of $9.63 to $9.83. The updated guidance assumes 3.5% to 4% organic revenue growth and includes contributions from acquisitions completed in 2024. Operational improvements and strong demand for innovative clinical solutions were highlighted as key growth enablers.
Strong Revenue Growth
Quest Diagnostics reported a 15.2% increase in consolidated revenues, with a 5.2% organic revenue growth and diagnostic information services revenues up by 15.7%.
Increased Earnings Per Share
Adjusted EPS grew by 11.5% to $2.62, compared to $2.35 the prior year, reflecting strong top-line growth and productivity gains.
Successful Acquisitions
Acquisitions contributed significantly to growth, with a notable 20% revenue growth in the physician channel and an 8% contribution to M&A growth from LifeLabs.
Operational Improvements
Quest continues to target 3% annual cost savings through its Invigorate program, with automation and AI technologies being deployed to improve quality and productivity.
Increased Cash Flow
Cash from operations increased by 67.1% year-over-year to $858 million, driven by higher operating income and a one-time CARES Act tax credit.
Raised Full-Year Guidance
Quest Diagnostics raised its full-year 2025 revenue guidance to between $10.8 billion and $10.92 billion, with adjusted EPS expected to be in a range of $9.63 to $9.83.

Quest Diagnostics (DGX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DGX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 28, 2025
2025 (Q3)
2.50 / -
2.3
Jul 22, 2025
2025 (Q2)
2.57 / 2.62
2.3511.49% (+0.27)
Apr 22, 2025
2025 (Q1)
2.15 / 2.21
2.048.33% (+0.17)
Jan 30, 2025
2024 (Q4)
2.19 / 2.23
2.153.72% (+0.08)
Oct 22, 2024
2024 (Q3)
2.26 / 2.30
2.223.60% (+0.08)
Jul 23, 2024
2024 (Q2)
2.33 / 2.35
2.32.17% (+0.05)
Apr 23, 2024
2024 (Q1)
1.86 / 2.04
2.040.00% (0.00)
Feb 01, 2024
2023 (Q4)
2.11 / 2.15
1.988.59% (+0.17)
Oct 24, 2023
2023 (Q3)
2.19 / 2.22
2.36-5.93% (-0.14)
Jul 26, 2023
2023 (Q2)
2.27 / 2.30
2.36-2.54% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DGX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 22, 2025
$166.45$178.24+7.08%
Apr 22, 2025
$161.13$172.06+6.78%
Jan 30, 2025
$153.98$162.63+5.62%
Oct 22, 2024
$145.28$155.23+6.85%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quest Diagnostics (DGX) report earnings?
Quest Diagnostics (DGX) is schdueled to report earning on Oct 28, 2025, Before Open (Confirmed).
    What is Quest Diagnostics (DGX) earnings time?
    Quest Diagnostics (DGX) earnings time is at Oct 28, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DGX EPS forecast?
          DGX EPS forecast for the fiscal quarter 2025 (Q3) is 2.5.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis